Literature DB >> 5735381

Laboratory and clinical experience with cephalexin.

A C Kind, D G Kestle, H C Standiford, W M Kirby.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5735381

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother (Bethesda)


× No keyword cloud information.
  8 in total

Review 1.  Cephalexin: a review of its antibacterial, pharmacological and therapeutic properties.

Authors:  T M Speight; R N Brogden; G S Avery
Journal:  Drugs       Date:  1972       Impact factor: 9.546

2.  Rate of binding of antibiotics to canine serum protein.

Authors:  N Waterman; L Scharfenberger; M J Raff
Journal:  Antimicrob Agents Chemother       Date:  1974-03       Impact factor: 5.191

3.  Use and control of cephalosporins.

Authors:  S Eykyn
Journal:  J Clin Pathol       Date:  1971-07       Impact factor: 3.411

Review 4.  Cephalosporins in gram-positive infections.

Authors:  J Symonds; A M Geddes
Journal:  Drugs       Date:  1987       Impact factor: 9.546

5.  Changes in gut flora after cephalexin treatment.

Authors:  H Gaya; P I Adnitt; P Turner
Journal:  Br Med J       Date:  1970-09-12

6.  Biological properties of three 3-heterocyclic-thiomethyl cephalosporin antibiotics.

Authors:  W E Wick; D A Preston
Journal:  Antimicrob Agents Chemother       Date:  1972-03       Impact factor: 5.191

7.  Cephalexin: absorption and excretion as related to renal function and hemodialysis.

Authors:  B E Reisberg; J M Mandelbaum
Journal:  Infect Immun       Date:  1971-04       Impact factor: 3.441

8.  Clinical studies of cefazolin and comparison with other cephalosporins.

Authors:  T Madhavan; E L Quinn; E Freimer; E J Fisher; F Cox; K Burch; D Pohlod
Journal:  Antimicrob Agents Chemother       Date:  1973-11       Impact factor: 5.191
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.